A clinical trial testing the effects of a Lyme disease vaccine proves to be successful so far in protecting the body from the infection.
A large drug trial studying the effects of Gammagard in stabilizing Alzheimer's disease proved to be ineffective.
The Food and Drug Administration stopped the drug trial of Sensipar after the death of a 14 year-old patient.
Senior citizens are at the top of the list of people at risk for contracting and unfortunately, passing away from the coronavirus. This is in great part due to their weaker immune systems and common existing health problems associated with aging. As such, it has been highly recommended that seniors do their best to remain at home to reduce the likelihood of contracting the virus.